FINALLY AFTER ALL THESE YEARS, WE ARE FINALLY IN GOOD HANDS!I don't know how many of you have seen Dr Vera's resume, but it surely is the most impressive I have seen. The fact that such an accomplished, experienced pro would take a look at TLT's ACT and it's potential and want in, is very assuring. IMO, the one void in TLT's resume was the lack of an experienced, accomplished Director of Clinical Development to develope and govern the trials and deal with the FDA etc. Now that we have her expertise I expect at least three of the following four accomplishments this year. BTD, continued positive trial results, an additional new trial for another indication, and lastly some type of deal on funding, licensing or something along commercial developement lines. For sure, I expect the share price to be substantially above where it is now. I believe people are now starting to see this potential and while the rest of the market is tanking, TLT remains near it's yearly high.